Measuring Disease Progression in Osteoarthritis
Tóm tắt
Radiographs are a commonly used tool to assess disease progression in osteoarthritis (OA). However, it is not the preferred method of defining and following OA progression. While it is moderately responsive to change in terms of standardised response means (SRM), it is insensitive to change in cartilage measures. MRI offers a much better assessment, and OA features are much better targeted for defining and following the disease progression. Using MRI, cartilage volume/thickness loss predicts knee replacement and has similar levels of sensitivity to discriminate treatments in clinical trials. Cartilage defect is another target which was found to also be an independent predictor of some OA outcomes. In addition to cartilage, another MRI target for diagnosis and assessment of OA progression is subchondral bone alterations, especially bone marrow lesions (BMLs). BMLs independently predict OA outcomes including knee replacement and are sensitive to progression. Targeting of BMLs by bone remodelling agents demonstrates that the natural history of the disease could be diminished. MRI-detected effusion and synovitis are also promising targets of OA progression. In addition, alterations in these tissues are promising outcome measures for clinical trials. Newer MRI methods of cartilage quality assessment, including signal intensity on T1 images and dGEMRIC, have been proposed for assessing early cartilage loss. However, the requirement for a contrast agent with dGEMRIC precludes its widespread use on safety grounds. Another promising imaging modality for OA is ultrasound. However, this approach warrants further exploration as, although it has demonstrated a wide set of advantages over other imaging modalities, there are still major limitations. Evidence for use of ultrasound indices for assessing disease progression is limited. At present, this imaging modality may be better suited as a diagnostic and an explanatory tool within clinical practice rather than large-scale studies or clinical trials.
Tài liệu tham khảo
Lane NE, Brandt K, Hawker G, et al. OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage. 2011;19:478–82.
Creamer P, Hochberg MC. Osteoarthritis. Lancet. 1997;350:503–8.
Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697–707.
Walsh DA, Chapman V. Bisphosphonates for osteoarthritis. Arthritis Res Ther. 2011;13:128.
Martel-Pelletier J, Pelletier JP. Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahisi Joint Dis Relat Surg. 2010;21:2–14.
Quasnichka HL, Anderson-MacKenzie JM, Tarlton JF, et al. Cruciate ligament laxity and femoral intercondylar notch narrowing in early-stage knee osteoarthritis. Arthritis Rheum. 2005;52:3100–9.
Anderson-MacKenzie JM, Billingham ME, Bailey AJ. Collagen remodeling in the anterior cruciate ligament associated with developing spontaneous murine osteoarthritis. Biochem Biophys Res Commun. 1999;258:763–7.
Pelletier J-P, Kapoor M, Martel-Pelletier J. Animal models of osteoarthritis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Wiesman MH, editors. Rheumatology. 6th ed. Philadelphia: Elsevier; 2014. p. 1454–61.
Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–26.
Lievense AM, Bierma-Zeinstra SM, Verhagen AP, et al. Prognostic factors of progress of hip osteoarthritis: a systematic review. Arthritis Rheum. 2002;47:556–62.
Roemer FW, Guermazi A, Niu J, et al. Prevalence of magnetic resonance imaging-defined atrophic and hypertrophic phenotypes of knee osteoarthritis in a population-based cohort. Arthritis Rheum. 2012;64:429–37.
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.
Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage. 2007;15:A1–56.
Jones G, Ding C, Scott F, et al. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004;12:169–74.
Bruyere O, Honore A, Rovati LC, et al. Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scand J Rheumatol. 2002;31:13–6.
Bedson J, Croft PR. The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Musculoskelet Disord. 2008;9:116.
Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27:1513–7.
Michel A, Kohlmann T, Raspe H. The association between clinical findings on physical examination and self-reported severity in back pain. Results of a population-based study. Spine. 1997;22:296–303.
Dahaghin S, Bierma-Zeinstra SM, Reijman M, et al. Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study). Ann Rheum Dis. 2005;64:99–104.
Bruyere O, Genant H, Kothari M, et al. Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritis. Osteoarthritis Cartilage. 2007;15:98–103.
Duryea J, Neumann G, Niu J, et al. Comparison of radiographic joint space width with magnetic resonance imaging cartilage morphometry: analysis of longitudinal data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2010;62:932–7.
Hall J, Laslett LL, Martel-Pelletier J, et al. Change in knee structure and change in tibiofemoral joint space width: a five year longitudinal population-based study. BMC Musculoskelet Disord. 2016;17:25.
Cicuttini F, Hankin J, Jones G, et al. Comparison of conventional standing knee radiographs and magnetic resonance imaging in assessing progression of tibiofemoral joint osteoarthritis. Osteoarthritis Cartilage. 2005;13:722–7.
Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther. 2006;8:R21.
Hunter DJ, Zhang YQ, Tu X, et al. Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? Arthritis Rheum. 2006;54:2488–95.
Hunter DJ, Zhang YQ, Niu JB, et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum. 2006;54:795–801.
Berthiaume MJ, Raynauld JP, Martel-Pelletier J, et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis. 2005;64:556–63.
Pelletier JP, Raynauld JP, Berthiaume MJ, et al. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Res Ther. 2007;9:R74.
Conaghan PG, Hunter DJ, Maillefert JF, et al. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage. 2011;19:606–10.
Reichmann WM, Maillefert JF, Hunter DJ, et al. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthritis Cartilage. 2011;19:550–6.
Hunter DJ, Zhang W, Conaghan PG, et al. Responsiveness and reliability of MRI in knee osteoarthritis: a meta-analysis of published evidence. Osteoarthritis Cartilage. 2011;19:589–605.
Aitken D, Ding C, Pelletier JP, et al. Responsiveness of magnetic resonance imaging-derived measures over 2.7 years. J Rheumatol. 2014;41:2060–7.
Conaghan PG, D’Agostino MA, Le Bars M, et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis. 2010;69:644–7.
Bruyere O, Richy F, Reginster JY. Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis. 2005;64:1727–30.
Cicuttini FM, Jones G, Forbes A, et al. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis. 2004;63:1124–7.
Hawker GA, Guan J, Croxford R, et al. A prospective population-based study of the predictors of undergoing total joint arthroplasty. Arthritis Rheum. 2006;54:3212–20.
Verbruggen G, Veys EM. Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints. Arthritis Rheum. 1996;39:308–20.
Verbruggen G, Wittoek R, Vander Cruyssen B, et al. Morbid anatomy of ‘erosive osteoarthritis’ of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected joints. Ann Rheum Dis. 2010;69:862–7.
Visser AW, Boyesen P, Haugen IK, et al. Radiographic scoring methods in hand osteoarthritis—a systematic literature search and descriptive review. Osteoarthritis Cartilage. 2014;22:1710–23.
Maheu E, Cadet C, Gueneugues S, et al. Reproducibility and sensitivity to change of four scoring methods for the radiological assessment of osteoarthritis of the hand. Ann Rheum Dis. 2007;66:464–9.
Bijsterbosch J, Haugen IK, Malines C, et al. Reliability, sensitivity to change and feasibility of three radiographic scoring methods for hand osteoarthritis. Ann Rheum Dis. 2011;70:1465–7.
Verbruggen G, Wittoek R, Vander Cruyssen B, et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis. 2012;71:891–8.
Kwok WY, Bijsterbosch J, Malm SH, et al. Validity of joint space width measurements in hand osteoarthritis. Osteoarthritis Cartilage. 2011;19:1349–55.
Hunter DJ, Arden N, Conaghan PG, et al. Definition of osteoarthritis on MRI: results of a Delphi exercise. Osteoarthritis Cartilage. 2011;19:963–9.
Haugen IK, Østergaard M, Eshed I, et al. Iterative development and reliability of the OMERACT Hand Osteoarthritis MRI Scoring System. J Rheumatol. 2014;41:386–91.
Pelletier JP, Cooper C, Peterfy C, et al. What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis. 2013;72:1594–604.
Hunter DJ, Zhang W, Conaghan PG, et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage. 2011;19:557–88.
Wildi LM, Martel-Pelletier J, Abram F, et al. Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons. Arthritis Care Res. 2013;65:686–94. This is the first head to head study demonstrating in an RCT that quantitative MRI is more sensitive than semi-quantitative methods in knee OA patient treatment response.
Raynauld JP, Martel-Pelletier J, Haraoui B, et al. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis. 2011;70:1382–8.
Raynauld JP, Martel-Pelletier J, Dorais M, et al. Total knee replacement as a knee osteoarthritis outcome: predictors derived from a 4-year long-term observation following a randomized clinical trial using chondroitin sulfate. Cartilage. 2013;4:219–26.
Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Ann Rheum Dis. 2008;67:683–8.
Eckstein F, Kwoh CK, Boudreau RM, et al. Quantitative MRI measures of cartilage predict knee replacement: a case–control study from the Osteoarthritis Initiative. Ann Rheum Dis. 2013;72:707–14.
Wildi LM, Raynauld JP, Martel-Pelletier J, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70:982–9.
Raynauld JP, Martel-Pelletier J, Bias P, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis. 2009;68:938–47.
Khan H, Aitken D, Ding C, et al. Natural history and clinical significance of cartilage defects over 10 years in a mid-life cohort[abstr]. Osteoarthritis Cartilage. 2015;23:A55–A6.
Wluka AE, Ding C, Jones G, et al. The clinical correlates of articular cartilage defects in symptomatic knee osteoarthritis: a prospective study. Rheumatology (Oxford). 2005;44:1311–6.
Gold GE, Hargreaves BA, Stevens KJ, et al. Advanced magnetic resonance imaging of articular cartilage. Orthop Clin North Am. 2006;37:331–47. vi.
Stannus OP, Jiang D, Cicuttini F, et al. Cartilage signal intensity on T1-weighted MRI: association with risk factors and measures of knee osteoarthritis. Clin Rheumatol. 2014;33:359–68.
Burstein D, Velyvis J, Scott KT, et al. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med. 2001;45:36–41.
Crema MD, Hunter DJ, Burstein D, et al. Association of changes in delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) with changes in cartilage thickness in the medial tibiofemoral compartment of the knee: a 2 year follow-up study using 3.0 T MRI. Ann Rheum Dis. 2014;73:1935–41.
Anandacoomarasamy A, Leibman S, Smith G, et al. Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage. Ann Rheum Dis. 2012;71:26–32.
Roos EM, Dahlberg L. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum. 2005;52:3507–14.
Dunn TC, Lu Y, Jin H, et al. T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology. 2004;232:592–8.
Jungmann PM, Kraus MS, Nardo L, et al. T(2) relaxation time measurements are limited in monitoring progression, once advanced cartilage defects at the knee occur: longitudinal data from the osteoarthritis initiative. J Magn Reson Imaging. 2013;38:1415–24.
Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003;139:330–6.
de Lange BJ, Ioan-Facsinay A, Bijsterbosch J, et al. The patellofemoral and femorotibial joints are related based on patterns of MRI features and their association with radiologic progression[abstr]. Osteoarthritis Cartilage. 2014;22:S254–S5.
Dore D, Martens A, Quinn S, et al. Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther. 2010;12:R222.
Roemer FW, Guermazi A, Javaid MK, et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis. 2009;68:1461–5.
Pelletier JP, Roubille C, Raynauld JP, et al. Disease-modifying effect of strontium ranelate in a subset of patients from the phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann Rheum Dis. 2015;74:422–9. This is the first study showing that a bone remodeling agent, strontium ranelate, significantly reduced, in addition to bone marrow lesions, the cartilage volume loss in knee OA patients.
Wluka AE, Hanna F, Davies-Tuck M, et al. Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis. 2009;68:850–5.
Davies-Tuck ML, Wluka AE, Forbes A, et al. Development of bone marrow lesions is associated with adverse effects on knee cartilage while resolution is associated with improvement—a potential target for prevention of knee osteoarthritis: a longitudinal study. Arthritis Res Ther. 2010;12:R10.
Teichtahl AJ, Wluka AE, Wang Y, et al. Effect of long-term vigorous physical activity on healthy adult knee cartilage. Med Sci Sports Exerc. 2012;44:985–92.
Tanamas SK, Wluka AE, Pelletier JP, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford). 2010;49:2413–9.
Scher C, Craig J, Nelson F. Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-up. Skeletal Radiol. 2008;37:609–17.
Roemer FW, Kwoh CK, Hannon MJ, et al. Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? Radiology. 2015;274:810–20.
Callaghan MJ, Parkes MJ, Hutchinson CE, et al. A randomized trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions. Ann Rheum Dis. 2015;74:1164–70. PF BMLs can change in as little as 6 weeks, and respond to PF knee bracing.
Laslett L, Dore D, Quinn S, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis. 2012;71:1322–8. This is the first study to demonstrate that in human knee OA patients, a bisphosphonate, zoledronic acid, can modify bone marrow lesions as well as reducing pain.
Koivisto K, Kyllonen E, Haapea M, et al. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging. BMC Musculoskelet Disord. 2014;15:64.
Laslett LL, Kingsbury SR, Hensor EM, et al. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Ann Rheum Dis. 2014;73:824–30.
Wildi LM, Raynauld JP, Martel-Pelletier J, et al. Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI. Ann Rheum Dis. 2010;69:2118–24.
Ahedi H, Aitken D, Blizzard L, et al. A population-based study of the association between hip bone marrow lesions, high cartilage signal, and hip and knee pain. Clin Rheumatol. 2014;33:369–76.
Haugen IK, Slatkowsky-Christensen B, Boyesen P, et al. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis[epub before print]. Ann Rheum Dis 2016;75:117–23.
Li W, Abram F, Pelletier JP, et al. Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging. Arthritis Res Ther. 2010;12:R173.
Pelletier JP, Raynauld JP, Abram F, et al. A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI. Osteoarthritis Cartilage. 2008;16 Suppl 3:S8–13.
Roemer FW, Kwoh CK, Hannon MJ, et al. What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the Osteoarthritis Initiative. Arthritis Rheum. 2015;67:2085–96.
Wang X, Blizzard L, Halliday A, et al. Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis 2016;75:519–25.
Ayral X, Pickering EH, Woodworth TG, et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis—results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13:361–7.
Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625–35.
Wenham CY, Hensor EM, Grainger AJ, et al. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis. Rheumatology (Oxford). 2012;51:2286–94.
Englund M, Guermazi A, Roemer FW, et al. Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: the Multicenter Osteoarthritis Study. Arthritis Rheum. 2009;60:831–9.
Sharma L, Eckstein F, Song J, et al. Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum. 2008;58:1716–26.
Roemer FW, Zhang Y, Niu J, et al. Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. Radiology. 2009;252:772–80.
Teichtahl AJ, Wluka AE, Wang Y, et al. The longitudinal relationship between changes in body weight and changes in medial tibial cartilage, and pain among community-based adults with and without meniscal tears. Ann Rheum Dis. 2014;73:1652–8. Weight loss slows down cartilage loss and improves pain in people with meniscal tears.
Roubille C, Martel-Pelletier J, Raynauld JP, et al. Meniscal extrusion promotes knee osteoarthritis structural progression: protective effect of strontium ranelate treatment in a phase III clinical trial. Arthritis Res Ther. 2015;17:82. Presence of meniscal extrusion can modify the response to treatment in knee OA patients.
Roemer FW, Felson DT, Wang K, et al. Co-localisation of non-cartilaginous articular pathology increases risk of cartilage loss in the tibiofemoral joint—the MOST study. Ann Rheum Dis. 2013;72:942–8.
Roubille C, Martel-Pelletier J, Abram F, et al. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort. Semin Arthritis Rheum. 2015;45:257–67.
Mancarella L, Addimanda O, Pelotti P, et al. Ultrasound detected inflammation is associated with the development of new bone erosions in hand osteoarthritis: a longitudinal study over 3.9 years. Osteoarthritis Cartilage. 2015;23:1925–32.
Mathiessen A, Slatkowsky-Christensen B, Kvien TK, et al. Ultrasound-detected inflammation predicts radiographic progression in hand osteoarthritis after 5 years[epub before print]. Ann Rheum Dis 2015. doi:10.1136/annrheumdis-2015-207241
Wenham CY, Grainger AJ, Hensor EM, et al. Methotrexate for pain relief in knee osteoarthritis: an open-label study. Rheumatology (Oxford). 2013;52:888–92.
Dodin P, Pelletier JP, Martel-Pelletier J, et al. Automatic human knee cartilage segmentation from 3D magnetic resonance images. IEEE Trans Biomed Eng 2010;57. These are the first MRI systems that assess in a fully quantitative automated fashion the cartilage volume [100] and bone marrow lesions [101] in knee OA patients.
Dodin P, Abram F, Pelletier J-P, et al. A fully automated system for quantification of knee bone marrow lesions using MRI and the osteoarthritis initiative cohort. J Biomed Graph Comput. 2013;3:51–65.
Dodin P, Martel-Pelletier J, Pelletier JP, et al. A fully automated human knee 3D MRI bone segmentation using the ray casting technique. Med Biol Eng Comput. 2011;49:1413–24.